nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—Schizophrenia—Prednisone—systemic scleroderma	0.0589	0.0589	CcSEcCtD
Oxprenolol—Emotional distress—Pentoxifylline—systemic scleroderma	0.0588	0.0588	CcSEcCtD
Oxprenolol—Bronchospasm—Pentoxifylline—systemic scleroderma	0.0154	0.0154	CcSEcCtD
Oxprenolol—Abnormal dreams—Mycophenolic acid—systemic scleroderma	0.0147	0.0147	CcSEcCtD
Oxprenolol—Bronchospasm—Mometasone—systemic scleroderma	0.0133	0.0133	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Captopril—systemic scleroderma	0.0126	0.0126	CcSEcCtD
Oxprenolol—Bronchospasm—Captopril—systemic scleroderma	0.0117	0.0117	CcSEcCtD
Oxprenolol—Cardiac failure—Mycophenolic acid—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Oxprenolol—Hypoglycaemia—Mycophenolic acid—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Oxprenolol—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.0106	0.0106	CcSEcCtD
Oxprenolol—Hypoglycaemia—Lisinopril—systemic scleroderma	0.00998	0.00998	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00988	0.00988	CcSEcCtD
Oxprenolol—Diplopia—Lisinopril—systemic scleroderma	0.00974	0.00974	CcSEcCtD
Oxprenolol—Palpitations—Pentoxifylline—systemic scleroderma	0.00966	0.00966	CcSEcCtD
Oxprenolol—Sweating increased—Leflunomide—systemic scleroderma	0.00954	0.00954	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.0089	0.0089	CcSEcCtD
Oxprenolol—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00875	0.00875	CcSEcCtD
Oxprenolol—Cardiac failure—Mycophenolate mofetil—systemic scleroderma	0.00875	0.00875	CcSEcCtD
Oxprenolol—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00873	0.00873	CcSEcCtD
Oxprenolol—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00862	0.00862	CcSEcCtD
Oxprenolol—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.00854	0.00854	CcSEcCtD
Oxprenolol—Hypotension—Pentoxifylline—systemic scleroderma	0.00834	0.00834	CcSEcCtD
Oxprenolol—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.00834	0.00834	CcSEcCtD
Oxprenolol—Bronchospasm—Lisinopril—systemic scleroderma	0.00828	0.00828	CcSEcCtD
Oxprenolol—Sweating increased—Lisinopril—systemic scleroderma	0.0082	0.0082	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00813	0.00813	CcSEcCtD
Oxprenolol—Insomnia—Pentoxifylline—systemic scleroderma	0.00807	0.00807	CcSEcCtD
Oxprenolol—Arthralgia—Mometasone—systemic scleroderma	0.00803	0.00803	CcSEcCtD
Oxprenolol—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00785	0.00785	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.0078	0.0078	CcSEcCtD
Oxprenolol—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00762	0.00762	CcSEcCtD
Oxprenolol—Palpitations—Captopril—systemic scleroderma	0.00732	0.00732	CcSEcCtD
Oxprenolol—Arthralgia—Captopril—systemic scleroderma	0.00705	0.00705	CcSEcCtD
Oxprenolol—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00705	0.00705	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00701	0.00701	CcSEcCtD
Oxprenolol—Bradycardia—Lisinopril—systemic scleroderma	0.00686	0.00686	CcSEcCtD
Oxprenolol—Dyspepsia—Mometasone—systemic scleroderma	0.00678	0.00678	CcSEcCtD
Oxprenolol—Fatigue—Mometasone—systemic scleroderma	0.00664	0.00664	CcSEcCtD
Oxprenolol—Thrombocytopenia—Captopril—systemic scleroderma	0.00662	0.00662	CcSEcCtD
Oxprenolol—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00657	0.00657	CcSEcCtD
Oxprenolol—Asthenia—Pentoxifylline—systemic scleroderma	0.0064	0.0064	CcSEcCtD
Oxprenolol—Hypotension—Captopril—systemic scleroderma	0.00632	0.00632	CcSEcCtD
Oxprenolol—Pruritus—Pentoxifylline—systemic scleroderma	0.00631	0.00631	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Oxprenolol—Arthralgia—Azathioprine—systemic scleroderma	0.00615	0.00615	CcSEcCtD
Oxprenolol—Insomnia—Captopril—systemic scleroderma	0.00611	0.00611	CcSEcCtD
Oxprenolol—Diarrhoea—Pentoxifylline—systemic scleroderma	0.0061	0.0061	CcSEcCtD
Oxprenolol—Abdominal pain—Mometasone—systemic scleroderma	0.00608	0.00608	CcSEcCtD
Oxprenolol—Palpitations—Leflunomide—systemic scleroderma	0.00603	0.00603	CcSEcCtD
Oxprenolol—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00601	0.00601	CcSEcCtD
Oxprenolol—Dyspepsia—Captopril—systemic scleroderma	0.00595	0.00595	CcSEcCtD
Oxprenolol—Cardiac failure—Prednisone—systemic scleroderma	0.00593	0.00593	CcSEcCtD
Oxprenolol—Dizziness—Pentoxifylline—systemic scleroderma	0.0059	0.0059	CcSEcCtD
Oxprenolol—Fatigue—Captopril—systemic scleroderma	0.00583	0.00583	CcSEcCtD
Oxprenolol—Arthralgia—Leflunomide—systemic scleroderma	0.00581	0.00581	CcSEcCtD
Oxprenolol—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00578	0.00578	CcSEcCtD
Oxprenolol—Palpitations—Mycophenolic acid—systemic scleroderma	0.00576	0.00576	CcSEcCtD
Oxprenolol—Psychotic disorder—Prednisone—systemic scleroderma	0.00565	0.00565	CcSEcCtD
Oxprenolol—Headache—Pentoxifylline—systemic scleroderma	0.00559	0.00559	CcSEcCtD
Oxprenolol—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00554	0.00554	CcSEcCtD
Oxprenolol—Asthenia—Mometasone—systemic scleroderma	0.00552	0.00552	CcSEcCtD
Oxprenolol—Hypotension—Azathioprine—systemic scleroderma	0.00551	0.00551	CcSEcCtD
Oxprenolol—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00546	0.00546	CcSEcCtD
Oxprenolol—Pruritus—Mometasone—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Oxprenolol—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00539	0.00539	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00538	0.00538	CcSEcCtD
Oxprenolol—Abdominal pain—Captopril—systemic scleroderma	0.00534	0.00534	CcSEcCtD
Oxprenolol—Nausea—Pentoxifylline—systemic scleroderma	0.0053	0.0053	CcSEcCtD
Oxprenolol—Diarrhoea—Mometasone—systemic scleroderma	0.00527	0.00527	CcSEcCtD
Oxprenolol—Hypotension—Leflunomide—systemic scleroderma	0.00521	0.00521	CcSEcCtD
Oxprenolol—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.0052	0.0052	CcSEcCtD
Oxprenolol—Palpitations—Lisinopril—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Oxprenolol—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00514	0.00514	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Oxprenolol—Insomnia—Leflunomide—systemic scleroderma	0.00504	0.00504	CcSEcCtD
Oxprenolol—Arthralgia—Lisinopril—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Oxprenolol—Hypotension—Mycophenolic acid—systemic scleroderma	0.00497	0.00497	CcSEcCtD
Oxprenolol—Dyspepsia—Leflunomide—systemic scleroderma	0.0049	0.0049	CcSEcCtD
Oxprenolol—Sweating increased—Prednisone—systemic scleroderma	0.00487	0.00487	CcSEcCtD
Oxprenolol—Asthenia—Captopril—systemic scleroderma	0.00485	0.00485	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Oxprenolol—Headache—Mometasone—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Oxprenolol—Insomnia—Mycophenolic acid—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Oxprenolol—Fatigue—Leflunomide—systemic scleroderma	0.0048	0.0048	CcSEcCtD
Oxprenolol—Pruritus—Captopril—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Oxprenolol—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00469	0.00469	CcSEcCtD
Oxprenolol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00468	0.00468	CcSEcCtD
Oxprenolol—Abdominal pain—Azathioprine—systemic scleroderma	0.00466	0.00466	CcSEcCtD
Oxprenolol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00463	0.00463	CcSEcCtD
Oxprenolol—Diarrhoea—Captopril—systemic scleroderma	0.00463	0.00463	CcSEcCtD
Oxprenolol—Fatigue—Mycophenolic acid—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Oxprenolol—Nausea—Mometasone—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Oxprenolol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Oxprenolol—Hypotension—Lisinopril—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Oxprenolol—Dizziness—Captopril—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Oxprenolol—Abdominal pain—Leflunomide—systemic scleroderma	0.0044	0.0044	CcSEcCtD
Oxprenolol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Oxprenolol—Hypersensitivity—Azathioprine—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Oxprenolol—Insomnia—Lisinopril—systemic scleroderma	0.00433	0.00433	CcSEcCtD
Oxprenolol—Headache—Captopril—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Oxprenolol—Dyspepsia—Lisinopril—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Oxprenolol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Oxprenolol—Fatigue—Lisinopril—systemic scleroderma	0.00413	0.00413	CcSEcCtD
Oxprenolol—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00411	0.00411	CcSEcCtD
Oxprenolol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00411	0.00411	CcSEcCtD
Oxprenolol—Bradycardia—Prednisone—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Oxprenolol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Oxprenolol—Diarrhoea—Azathioprine—systemic scleroderma	0.00404	0.00404	CcSEcCtD
Oxprenolol—Nausea—Captopril—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Oxprenolol—Asthenia—Leflunomide—systemic scleroderma	0.004	0.004	CcSEcCtD
Oxprenolol—Pruritus—Leflunomide—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Oxprenolol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Oxprenolol—Dizziness—Azathioprine—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Oxprenolol—Asthenia—Mycophenolic acid—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Oxprenolol—Diarrhoea—Leflunomide—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Oxprenolol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Oxprenolol—Abdominal pain—Lisinopril—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Oxprenolol—Pruritus—Mycophenolic acid—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Oxprenolol—Headache—Azathioprine—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Oxprenolol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Oxprenolol—Dizziness—Leflunomide—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Oxprenolol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Oxprenolol—Hypersensitivity—Lisinopril—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Oxprenolol—Dizziness—Mycophenolic acid—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Oxprenolol—Nausea—Azathioprine—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Oxprenolol—Headache—Leflunomide—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Oxprenolol—Asthenia—Lisinopril—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Oxprenolol—Pruritus—Lisinopril—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Oxprenolol—Headache—Mycophenolic acid—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Oxprenolol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Oxprenolol—Nausea—Leflunomide—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Oxprenolol—Diarrhoea—Lisinopril—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Oxprenolol—Dizziness—Lisinopril—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Oxprenolol—Nausea—Mycophenolic acid—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Oxprenolol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Oxprenolol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Oxprenolol—Headache—Lisinopril—systemic scleroderma	0.003	0.003	CcSEcCtD
Oxprenolol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Oxprenolol—Arthralgia—Prednisone—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Oxprenolol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Oxprenolol—Nausea—Lisinopril—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Oxprenolol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Oxprenolol—Hyperhidrosis—Prednisone—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Oxprenolol—Headache—Mycophenolate mofetil—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Oxprenolol—Insomnia—Prednisone—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Oxprenolol—Dyspepsia—Prednisone—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Oxprenolol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Oxprenolol—Arthralgia—Methotrexate—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Oxprenolol—Fatigue—Prednisone—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Oxprenolol—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Oxprenolol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Oxprenolol—Abdominal pain—Prednisone—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Oxprenolol—Hypotension—Methotrexate—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Oxprenolol—Insomnia—Methotrexate—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Oxprenolol—Hypersensitivity—Prednisone—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Oxprenolol—Dyspepsia—Methotrexate—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Oxprenolol—Fatigue—Methotrexate—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Oxprenolol—Asthenia—Prednisone—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Oxprenolol—Pruritus—Prednisone—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Oxprenolol—Diarrhoea—Prednisone—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Oxprenolol—Dizziness—Prednisone—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Oxprenolol—Abdominal pain—Methotrexate—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Oxprenolol—Headache—Prednisone—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Oxprenolol—Hypersensitivity—Methotrexate—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Oxprenolol—Asthenia—Methotrexate—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Oxprenolol—Nausea—Prednisone—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Oxprenolol—Pruritus—Methotrexate—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Oxprenolol—Diarrhoea—Methotrexate—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Oxprenolol—Dizziness—Methotrexate—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Oxprenolol—Headache—Methotrexate—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Oxprenolol—Nausea—Methotrexate—systemic scleroderma	0.00141	0.00141	CcSEcCtD
